Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Syros Pharmaceuticals (SYRS.US)$ Reuters· 1 min ago1min
Syros Announces Topline Data From Select-Mds-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome With Rara Gene Overexpression! Did not meet endpoint!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
1
2
+0
Translate
Report
5993 Views
Comment
Sign in to post a comment